"Breakthrough: Telescopes - The Truth is Out There" Premieres March 5 SILVER SPRING, MARYLAND / ACCESS Newswire / March ...
Iopofosine-131 has been granted breakthrough therapy designation by the FDA for relapsed or refractory Waldenstrom macroglobulinemia, indicating its potential to improve treatment outcomes. The phase ...
Findings showed in the rinatabart sesutecan 100mg/m 2 cohort, the confirmed ORR was 50%, with 2 patients achieving complete response. The Food and Drug Administration (FDA) has granted Breakthrough ...
Sonrotoclax, a BCL2 inhibitor, received FDA breakthrough therapy designation for relapsed or refractory mantle cell lymphoma, indicating its potential to transform patient outcomes. The drug is ...
WESTFIELD, Ind., Feb. 17, 2026 /PRNewswire/ -- Today, Portal Diabetes, Inc. ("Portal") announced its receipt of the Breakthrough Device Designation by the Food and Drug Administration (FDA) for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results